Engineering of Recombinant Endolysin LysSi3 to Increase its Antibacterial Properties

The potential of new genetically modified recombinant endolysins as antimicrobial agents against Gram-negative bacteria was investigated. A series of enzymes based on LysSi3 lysozyme-like muramidase was obtained by modifying its sequence with antimicrobial peptides of different families, and recombi...

Full description

Saved in:
Bibliographic Details
Published in:Applied biochemistry and microbiology 2024-10, Vol.60 (5), p.802-811
Main Authors: Antonova, N. P., Grigoriev, I. V., Lendel, A. M., Usacheva, O. V., Klimova, A. A., Usachev, E. V., Gushchin, V. A., Vasina, D. V.
Format: Article
Language:English
Subjects:
Antimicrobial agents
Antimicrobial peptides
Bacteria
Biochemistry
Biomedical and Life Sciences
Cell lines
Cytotoxicity
E coli
Genetic modification
Gram-negative bacteria
Life Sciences
Lysins
Lysozyme
Medical Microbiology
Microbiology
Peptides
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The potential of new genetically modified recombinant endolysins as antimicrobial agents against Gram-negative bacteria was investigated. A series of enzymes based on LysSi3 lysozyme-like muramidase was obtained by modifying its sequence with antimicrobial peptides of different families, and recombinant expression in E. coli was demonstrated. Modification of LysSi3 resulted in increased bacteriolytic activity against the model isolate of A. baumannii and a higher kinetics rate compared to the native enzyme. The cytotoxic properties of the newly engineered lysins were investigated with the HEK293 and HaCaT cell lines, and it was shown that modification of LysSi3 with antimicrobial peptides does not significantly increase the toxic properties in vitro.
ISSN:0003-6838
1608-3024
DOI:10.1134/S000368382460492X